Skip to content

International Survey of Acute Coronary Syndromes

International Survey of Acute Coronary Syndromes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01218776
Acronym
ISACS
Enrollment
36000
Registered
2010-10-11
Start date
2010-09-28
Completion date
2026-12-31
Last updated
2025-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Coronary Disease, Myocardial Infarction, Unstable Angina Pectoris

Keywords

Acute Coronary Syndrome, Eastern Europe, Therapies

Brief summary

The International Registry of Acute Coronary Syndromes registry study (ISACS) is both a retrospective and prospective study which was designed in order to obtain data of patients with acute coronary syndromes, and herewith control and optimize internationally guideline-recommended therapies in these countries

Detailed description

Aims of this survey study are (1) documentation of the characteristics of all patients presenting to the ISACS centers with STEMI or NSTEMI (2) documentation of in-hospital outcome, and outcome rates at 6 month and 1 year, (3) documentation of invasive procedures and procedure-associated complications (4) documentation of therapeutic regimens and investigation conformity of treatment with already established guidelines. Investigators: ISACS Administrative Committee: Raffaele Bugiardini (Italy-Principal Investigator) Lina Badimon (Spain) Olivia Manfrini (Italy- Project Coordinator) Edina Cenko (Italy-Center Coordinator) Steering Committee: Mirza Dilic (Bosnia and Herzegovina), Asen Goudev (Bulgaria), Davor Milicic (Croatia), Raffaele Bugiardini, Edina Cenko and Olivia Manfrini (Italy) Gani Bajraktari (Kosovo), Andrejs Erglis and Ilja Zakke (Latvia), Remigius Zaliunas and Olivija Gustiene (Lithuania), Sasko Kedev and Marija Vavlukis (North Macedonia), Mihail Popovici (Moldova), Maria Dorobantu (Romania), Zorana Vasiljevic (Serbia), Eva Goncalvesova and Martin Studenkan (Slovakia) , Alexander N. Parkhomenko (Ukraine) , Christopher P Gale (United Kingdom).

Interventions

None listed

Sponsors

University of Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* acute coronary syndromes

Exclusion criteria

* under age or not able to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
All causes mortality30 days, 6 months, 1 yearAll causes mortality

Secondary

MeasureTime frameDescription
Cardiovascular mortality30 days, 6 months, 1 yearCardiovascular mortality
Recurrent myocardial infarction30 days, 6 months, 1yearRecurrent myocardial infarction
Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes6 month, 1 yearPharmacogenetic and cardiovascular genetic studies associated to clinical outcomes
Adherence to internationally guideline recommended therapies across the participating countriesdischarge, 6 months, 1 yearAdherence to internationally guideline recommended therapies across the participating

Countries

Italy

Contacts

Primary ContactRaffaele Bugiardini, MD
raffaele.bugiardini@unibo.it+39 335 5612962
Backup ContactLina Badimon, MD
badimon@csic-iccc.org+34 670296741

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026